ArticleJournal of global health2026
Association of caesarean section history with adverse pregnancy outcomes in placenta accreta spectrum: the mediating role of placenta previa.
Article in Journal of global health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Placenta accreta spectrum (PAS) is a leading cause of severe maternal and neonatal complications, yet its risk pathways remain incompletely understood. We aimed to evaluate the association between the number of prior caesarean sections (CS) and adverse maternal and neonatal outcomes in PAS, and to quantify the mediating role of placenta previa (PP) in this relationship. Methods: Based on a retrospective cohort of 231 patients with PAS (61 with no prior CS, 124 with one CS, and 46 with ≥2 CS), we performed multivariate logistic regression to assess associations between CS history and pregnancy outcomes and conducted mediation analysis to estimate the proportion of the CS effect mediated by PP. Results: Patients with ≥2 prior CS had significantly higher rates of second-trimester surgical abortion, percreta, and higher PAS severity scores. While PP, embolisation, blood transfusion, and prolonged hospitalisation were more common in women with any CS history, their frequencies did not increase proportionally with the number of CS. Multivariate analysis demonstrated that a higher number of prior CS was independently associated with increased risks of invasive PAS, massive intraoperative haemorrhage and transfusion, and preterm delivery. Mediation analysis showed that PP contributed to 8.62% of the association between CS history and invasive PAS, 16.93% for transfusion, 32.83% for preterm birth, and 11.40% for neonatal intensive care unit admission. Conclusions: A higher number of previous CS procedures in our sample was associated with higher risks of several adverse maternal outcomes in PAS. Neonatal outcomes, however, were not significantly influenced by the number of prior CS procedures and were more strongly affected by the gestational age at delivery. These relationships were partially mediated by PP, highlighting its important, but incomplete role in the pathway linking prior CS to PAS-related complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.